• Coverage for Individuals with Diabetes (HB53)

Delivery of Necessary Diabetic Supplies

HB 53 strengthens diabetes-related requirements for New Mexico health insurers by mandating consistent coverage of diabetes supplies, equipment, appliances, and self-management and nutrition therapy, while ensuring timely delivery of these medically necessary resources. It requires insurers to maintain adequate supplier networks, monitor delivery performance, and reimburse members when delays force them to pay out of pocket, including interest on late payments. The bill also establishes a quarterly statutory data call requiring insurers to report reimbursement demands, delivery failures, and related complaints to the Office of the Superintendent of Insurance.


Diabetic Supplies Resources

Reporting period: The Health Plans are required to submit on a quarterly basis. This report is due by the 30th day of the month following the end of the reporting quarter. If a report due date falls on a weekend or a State of New Mexico holiday, receipt of the report the next business day is acceptable. Please adhere to the following reporting periods and due dates:

Quarter

Reporting Period

Report Due Date

1

January 1 – March 31

April 30

2

April 1 – June 30

July 30

3

July 1- September 30

October 30

4

October 1 – December 31

January 30

Recent News

Get the latest information about rule changes, legislation, industry information and consumer news.

Read All OSI News

MEDICAL MALPRACTICE PREMIUM REDUCTION

AMENDED BULLETIN 2026-010: The New Mexico State Legislature appropriated $5 million to the New Mexico Office of Superintendent of Insurance (OSI) to address medical malpractice insurance costs for individual providers. The appropriation was part of a supplemental appropriation package passed in 2025. This one-time appropriation directs OSI to provide a premium subsidy for private medical malpractice insurance policies. […]

Read More

NOTICE OF PRESCRIPTION DRUG PRICE TRANSPARENCY ANNUAL MEETING

The Office of the Superintendent of Insurance will hold its annual public meeting to present and discuss the findings and recommendations contained in the 2025 Prescription Drug Price Transparency legislative report. The purpose of this meeting is to inform the public of the report’s contents and to provide an opportunity for public comments and questions. […]

Read More